Trials / Completed
CompletedNCT06747143
Short-term Immunomodulatory Effects of Lactobacillus Casei DN-114001: Impacts on Gut Microbiota Composition and Systemic Immune Biomarkers in Healthy Adults
"Study of Immunological Biomarkers in Response to Probiotic Intake"
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- University of Valladolid · Academic / Other
- Sex
- All
- Age
- 19 Years – 46 Years
- Healthy volunteers
- Accepted
Summary
The study included 21 adult participants, aged 19-46 years (19 female participants and 2 male participants). The selection criteria included the following parameters: Body Mass Index (BMI), calculated as weight (kg) divided by height squared (m²), between 18.5 and 29.99; Waist-to-Hip Ratio with thresholds set at \>0.90 for males and \>0.85 for females for individuals with normal weight (eutrophic); percentage of body fat: Considered within normal range if \<30% for individuals with normal weight. Standard biochemical and anthropometric measurements were carried out to all the subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Lactobacillus casei DN-114001 | Probiotic |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2013-04-01
- Completion
- 2013-09-01
- First posted
- 2024-12-24
- Last updated
- 2025-01-06
Source: ClinicalTrials.gov record NCT06747143. Inclusion in this directory is not an endorsement.